Skip to Navigation
Skip to Main Content
Skip to Related Content
to view your mail
Yahoo Finance Plus
U.S. markets closed
Russell 2000 Futures
Cidara Therapeutics, Inc. (CDTX)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
788 reactions on $CDTX conversation
Sign in to post a message.
CDTX is a sleeper that will awaken 2022 good pipeline in the works and FDA approval and $5+ coming soon 2022. and possible buyout from Janessen pharms collaboration. CDTX is still rated Buy from several reputable analysts.......I buying at this level.
CDTX 1st. Qtr. 2022 are looking pretty decent Revenues way up and earnings have taking a turn for the better too. I bought more shares today it's going to survive and thrive. Good pipeline is getting bigger. $5+ in 2022 is not out of the question. CDTX is a promising investment
HC Wainwright lowered the price target to $6 from $7.50, citing the challenging capital market environment.
Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock
May 12, 2022
Are we going up to $1?
this company need to be acquired that is the only thing that would make sense
Good news today for CDTX holders
Who us buying? why no insider buys?
CDTX has had some Strong Buy/buy ratings for awhile this good news this week seems to justify ratings now CDTX is worth buying & holding onto at these prices.
This little stock is full of potential CDTX good stuff in it's pipeline good news with FDA final approval could push $5+ eventually. I see back over $1 or $2 soon. buying & holding this one.
is there any news
Some Good news is coming out. Volume and Share price going higher looke the back over $1? Wowee zowee
CDTX shares 47% owned by Big Funds. CDTX has had new drug approved recently and has others doing good in trials right now. This one has alot of potential growth 2022 Buy and Hold investment here
Monday we shall see how the stock fares after the presentations in Lisbon
I beieve this little CDTX has the ability to go much higher, why? because the have some good new anti-fungal drugs in their pipeline that passed phase 3 trials and more coming. Buy&Hold this one.
Yahoo Finance Insights
Cidara Therapeutics is up 10.33% to 0.78
FiH CD388: check!
Rezafungin Awarded Promising Innovation Medicine (PIM) Designation by the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) for the Treatment of Invasive Candidiasis
Check the YF Summary tab... GLTA!
This just had the exact same market response as another successful anti-fungal company (SCYX). In the case of Scynexis, they were granted full FDA approval. Stock price tanked and is still trying to recover. This theme is playing out across the biotech space all year. Great news, stock drops. It certainly feels like Wall Street is focused on depressing this sector. I'm invested in multiple bio's that have achieved big milestones and all have low to no debt, cash in hand and otherwise should be promising investments that have the potential for large gains, but all of them are in the red and no one has any insights on why. I have only one recourse which is to hold and wait for Wall Street to decide to start pumping $$ back into the sector.
(CDTX) Market Cap $74 million / Cash balance $75 million / Big Phase 3 readout by next Quarter / has Dealswith big Pharma like Mundipharma & Janssen worth $1.3 BILLION =MASSIVE underpriced stock with huge upside .More informations see below :
7 million trades and they expect shareholders to believe its all sell orders. possible, but manipulation is more likely. in for 15,500 shares.
Why's this stock at $1.60 if it's waiting on Phase 3 data? Either is woefully undervalued or just a lemon. Hopefully it's the former.
US appeals court rejects Florida social media law, finds tech giants have First Amendment rights
Arby’s launches its first-ever burger made with Wagyu beef
Yahoo Finance Video
Henry Kissinger: Ukraine must give Russia territory
© 2022 Yahoo. All rights reserved.
About Our Ads